Teva Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	39,959	35,807	25,006	11,703	10,129	8,835
Market Cap Growth	61.92%	43.19%	113.68%	15.54%	14.65%	-16.46%
Enterprise Value	53,633	50,699	41,281	30,334	30,275	31,945
Last Close Price	34.31	31.21	22.04	10.44	9.12	8.01
PE Ratio	28.36	25.40	-	-	-	21.19
Forward PE	12.79	12.07	8.35	4.21	3.63	3.02
PS Ratio	2.28	2.08	1.51	0.74	0.68	0.56
PB Ratio	4.99	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	34.81	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	24.23	21.71	20.05	8.56	6.37	11.07
PEG Ratio	11.37	1.82	6.69	0.40	1.63	0.68
EV/Sales Ratio	3.11	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	10.83	10.23	9.31	6.99	7.63	7.25
EV/EBIT Ratio	13.57	12.83	12.24	9.52	11.37	10.38
EV/FCF Ratio	46.72	44.16	55.12	36.03	29.06	135.36
Debt / Equity Ratio	2.18	2.18	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	3.39	3.39	3.98	4.53	5.26	5.19
Debt / FCF Ratio	15.01	15.01	24.28	24.08	20.80	99.97
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.69	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.54	0.54	0.50	0.54	0.57	0.61
Current Ratio	1.04	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	20.79%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	6.17%	6.17%	5.09%	4.55%	3.63%	3.91%
Return on Invested Capital (ROIC)	18.07%	18.73%	14.74%	12.10%	8.85%	6.18%
Return on Capital Employed (ROCE)	14.50%	14.50%	12.70%	10.20%	8.20%	8.40%
Earnings Yield	3.53%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	2.87%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

Updated Jan 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q